Open AccessPneumocystis Jirovecii Pneumonia as a Sequela of COVID-19
Author(s) -
Syed Muhammad Zubair,
Hamid Hussain Muhammad Zaid,
Talha Shahzad
Publication year - 2021
Publication title -
journal of biomedical research and environmental sciences
Language(s) - English
Resource type - Journals
ISSN - 2766-2276
DOI - 10.37871/jbres1253
Subject(s) - medicine , bronchoalveolar lavage , sequela , pneumonia , pneumocystis jirovecii , tocilizumab , covid-19 , methylprednisolone , bronchoscopy , pediatrics , surgery , lung , infectious disease (medical specialty) , disease
A 71 years old male came to the hospital with the complaint of cough and fever since 7 days. He was diagnosed with severe COVID pneumonia and was managed with steroids and tocilizumab. He was discharged on steroids and came after 20 days with complaints of worsening shortness of breath and hypoxia. Bronchoscopy and bronchoalveolar lavage was done which showed positive PCR for Pneumocystis Jirovecii Pneumonia (PCP). Patient was started on co-trimoxazole and steroids after which he showed remarkable improvement. This is one of the rare cases in which patient developed PCP as a sequelae of COVID-19.